ER, PR, and HER2 expressions were interpreted according to the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines for hormone receptor and HER2 testing in breast cancer [13,14]. The gene discussed is ERBB2; the disease is breast carcinoma.